Case Remain for Bal...
Health Care: Drugs
Cell Therapeutics Inc. (CTIC: NASDAQ)
$1.22 0.00 | -0.08%
05/21/13 - 09:35 AM ET
65.06K / 974.50K
Vol / Avg. Vol:1.22 / 1.22
Open / Prev. Close:1.20 - 1.22
Today's Range:1.02 - 5.25
52 Wk Range:-10.77%
Performance YTD:TheStreet Rating:
Portfolios with CTIC
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- UserBiotech88
- ContributorUnder-$10 Setting Up To Tra...
- User2012 stock
- ContributorCancer Drug Stocks to Trade...
- UserImagine!
- Userfrankiesun09@gmail.com
- UserASCO 2010
- Contributor10 Biotech Stocks Facing FD...
- Userbiotech121
Latest CTIC Headlines from TheStreet
- Cell Therapeutics: Addicted to Reverse Stock Splits 04.18.13 | 10:04 am
- 13 Biotech Stock Predictions for 2013 01.02.13 | 06:01 am
- The Worst Biotech CEO of 2012 Is... 12.07.12 | 09:12 am
- Your Vote Counts: Who Is the Worst Biotech CEO of 2012? 12.04.12 | 08:12 am
- Genta: 1998-2012 10.25.12 | 07:10 am
- Peregrine Pharma's Lung Cancer Drug: Boffo Survival Benefit but How Real? 09.09.12 | 12:09 pm
- Cell Therapeutics' CEO Hosts Annual Shareholder Meeting (Transcript) 08.31.12 | 03:08 pm
- 2012 Biotech Stock Predictions: An Interim Report Card 08.28.12 | 07:08 am
- Cell Therapeutics Management Discusses Q2 2012 Results - Earnings Call Transcript 08.01.12 | 03:08 pm
- Cell Therapeutics Juggles Chainsaws To Distract Investors From Its Dead-End Course 04.19.12 | 03:04 pm
Press Releases for CTIC
- Draft NICE Guidance For Aggressive Non-Hodgkin Lymphoma Treatment, PIXUVRI® (pixantrone) - PR Newswire 04.10.13 | 07:04 pm
- Cell Therapeutics Secures $15 Million Loan Financing Agreement - PR Newswire 03.28.13 | 01:03 am
- Cell Therapeutics To Present At The ROTH Capital Partners 25th Annual Growth Stock Conference - PR Newswire 03.11.13 | 01:03 am
- Tosedostat OPAL Study In Acute Myeloid Leukemia Published In Lancet Oncology - PR Newswire 03.04.13 | 01:03 am
- German Institute For Quality And Efficiency In Health Care (IQWiG) Publishes Dossier Evaluation Within Early Benefit Assessment Process Of PIXUVRI® (pixantrone) - PR Newswire 03.01.13 | 09:03 pm
- German Institute For Quality And Efficiency In Health Care (IQWiG) Publishes Dossier Evaluation Within Early Benefit Assessment Process Of PIXUVRI® (pixantrone) - PR Newswire 03.01.13 | 08:03 pm
- Cell Therapeutics To Report Fourth Quarter And Full Year 2012 Financial Results After Market On February 28, 2013 - PR Newswire 02.26.13 | 01:02 am
- Cell Therapeutics Announces Data Safety And Monitoring Board Recommendation To Continue The GOG-0212 Phase 3 Clinical Trial Of OPAXIOTM As Maintenance Therapy In Ovarian Cancer - PR Newswire 01.31.13 | 01:01 am
- Cell Therapeutics To Host Analyst And Investor Meeting On Advances And Existing Challenges In The Treatment Of Myelofibrosis With Live Webcast - PR Newswire 01.16.13 | 01:01 am
- Cell Therapeutics Begins Enrollment In Phase 3 PERSIST-1 Trial Of Pacritinib For The Treatment Of Myelofibrosis - PR Newswire 01.09.13 | 01:01 am
Partner Headlines for CTIC
- Under Construction Rehash: Buy Acadia And Astex - Seeking Alpha 09.20.12 | 09:09 am
- Morning Market Movers - Benzinga 09.11.12 | 09:09 am
- Astex's Linear Rise Versus Peregrine's And Cell Therapeutics' Sudden Pop - Seeking Alpha 09.10.12 | 09:09 am
- Cell Therapeutics Says Holders Approve SBio Transaction - Benzinga 08.31.12 | 04:08 pm
- 5 Biotech Stocks That Could Double - Seeking Alpha 02.01.12 | 07:02 am
- Cell Therapeutics Plummeting on NDA Withdrawl - Benzinga 01.30.12 | 09:01 am
- US Panel to Review CTIC's Pixantrone - Analyst Blog - Zacks 01.04.12 | 10:01 am
- Mid-Day Update: Stocks Higher; Investors Cheer European Fiscal Deal - NASDAQ 12.09.11 | 05:12 pm
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 11.11.11 | 09:11 am
